Want to see BDRX full AI Analyst Report?
Biodexa Pharmaceuticals (BDRX) Q2 2024 Earnings Report
BDRX Q2 2024 EPS Results
- Actual EPS
- -$13.40
- Consensus EPS
- -$8.94
- Beat/Miss
- Missed by -$4.46
- One Year Ago EPS
- ―
BDRX Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $17.00K
- Beat/Miss
- Missed by -$17.00K
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 09/26/2024
- Time
- Before Open
- Conference Call
- Thursday, September 26, 2024
BDRX Upcoming Earnings
Biodexa Pharmaceuticals's next earnings date is estimated for April 23, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
BDRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 23, 2027 | 2026 (Q4) | ―- | 0 | ― | ― |
| Sep 11, 2026 | 2026 (Q2) | 0.000.00 | 0 | 100.00% (+0.00) | |
| Mar 27, 2026 | 2025 (Q4) | ―-0.01 | -0.27 | 98.11% (+0.26) | |
| Sep 12, 2025 | 2025 (Q2) | -0.16-0.01 | -13.4 | 99.92% (+13.39) | |
| Apr 11, 2025 | 2024 (Q4) | -0.26-0.27 | -141.79 | 99.81% (+141.52) | |
| Sep 26, 2024 | 2024 (Q2) | -8.94-13.40 | ― | ― | |
| Apr 19, 2024 | 2023 (Q4) | -141.68-141.79 | -4358192.2 | 100.00% (+4358050.41) | |
| Sep 29, 2023 | 2023 (Q2) | ―- | -80573.64 | ― | |
| Apr 28, 2023 | 2022 (Q4) | ―-4358192.20 | -2553013.98 | -70.71% (-1805178.21) | |
| Sep 14, 2022 | 2022 (Q2) | ―-402868.20 | -692006.41 | 41.78% (+289138.22) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed